Patient Benefits Justify Price of New Lupus Nephritis Drugs Patient Benefits Justify Price of New Lupus Nephritis Drugs

Prices of two new drugs approved by the FDA for lupus nephritis are in reasonable alignment with their estimated benefits for patients with the disease, a report indicates.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Nephrology News Source Type: news